Bluebird Bio Inc (BLUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 221,755 | 165,347 | 172,872 | 239,045 | 113,006 |
| Marketable Securities | N/A | 8,946 | 72,431 | 79,212 | 67,321 |
| Receivables | 560 | 23,000 | N/A | N/A | 14,627 |
| Inventories | 22,919 | 20,969 | 13,642 | 3,809 | N/A |
| Other current assets | 21,651 | 17,383 | 15,435 | 15,539 | 0 |
| TOTAL | $281,685 | $247,076 | $287,977 | $351,071 | $203,572 |
| Non-Current Assets | |||||
| PPE Net | 65,936 | 9,972 | 10,227 | 8,718 | 67,636 |
| Investments And Advances | 0 | 0 | 0 | 0 | 1,414 |
| Intangibles | 16,084 | 11,014 | 11,136 | 11,259 | 10,514 |
| Other Non-Current Assets | 255,456 | 345,546 | 354,053 | 321,688 | 286,678 |
| TOTAL | $337,476 | $366,532 | $375,416 | $341,665 | $366,242 |
| Total Assets | $619,161 | $613,608 | $663,393 | $692,736 | $569,814 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,520 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 18,498 | 19,852 | 10,894 | 19,235 | 14,867 |
| Accrued Expenses | 73,188 | 57,768 | 56,531 | 45,294 | 53,464 |
| TOTAL | $200,113 | $158,957 | $135,016 | $115,933 | $156,579 |
| Non-Current Liabilities | |||||
| Long Term Debt | 37,732 | N/A | N/A | N/A | 69,682 |
| Deferred Revenues | N/A | 9,653 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 186,779 | 232,115 | 239,358 | 222,063 | 209,220 |
| TOTAL | $224,511 | $232,115 | $239,358 | $222,063 | $278,902 |
| Total Liabilities | $424,624 | $391,072 | $374,374 | $337,996 | $435,481 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 9,696 | 5,467 | 5,348 | 5,321 | 5,319 |
| Common Shares | 1,905 | 1,071 | 1,065 | 1,064 | 830 |
| Retained earnings | -4,260,328 | -4,109,902 | -4,038,171 | -3,965,263 | -4,048,415 |
| Other shareholders' equity | -1,796 | -2,227 | -2,364 | -3,086 | -4,070 |
| TOTAL | $194,537 | $222,536 | $289,019 | $354,740 | $134,333 |
| Total Liabilities And Equity | $619,161 | $613,608 | $663,393 | $692,736 | $569,814 |